Sagent Pharmaceuticals acquisition of manufacturing site

Mar 17, 2019

Sagent Pharmaceuticals announces acquisition of manufacturing site in North Carolina providing Sagent with the potential to produce both small molecule and biologic products. This is the first FDA approved facility in the Nichi-Iko Group.